Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Mr. Jagdish Agrawal, Promoter (M.D.)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Jagdish Agrawal, Promoter and Managing Director of Ishita Drugs & Industries Ltd, acquired 254 equity shares (face value Rs. 10 each) through the open market on December 29, 2025. His holding increased marginally from 1,31,555 shares (4.40%) to 1,31,809 shares (4.41%) of the company's paid-up capital. The company has 29,90,300 equity shares outstanding (Rs. 2,99,03,000 total capital). The change is negligible in size — about 0.01% of the company's share capital — and was done via open market purchase.
This is a very small, routine open-market purchase by an individual promoter that has no meaningful impact on shareholding pattern or stock price. It signals minor promoter confidence but is too small to indicate any strategic shift in ownership.